RNA-seq analysis of an Scn1a+/- mouse model of Dravet syndrome identified Gpr55 as a candidate genetic modifier [27]. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.